BCL2 and cancer: This equilibrium is affected by the expression level of the different BCL-2 proteins—indeed, one of the most often occurring chemo-resistance mechanism is ascribed to the overexpression of anti-apoptotic proteins in several types of cancer, for example in hematologic malignancies [41,42].